NCT01247012View on ClinicalTrials.gov

Minimization of IntraLipid Versus Omegaven

PHASE2/PHASE3UnknownINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

December 31, 2010

Primary Completion Date

December 31, 2012

Study Completion Date

December 31, 2012

Conditions
CholestasisParenteral Nutrition Associated Liver Disease (PNALD)
Interventions
DIETARY_SUPPLEMENT

Omegaven

Omegaven 1g/kg/day until infant receiving full enteral feeds

DIETARY_SUPPLEMENT

Lipid minimization

"1g/kg/day daily until infant receiving full enteral feeds~IF conjugated bili rises above 100, crossover to Omegaven (1gram/kg/day)"

Trial Locations (1)

Unknown

RECRUITING

Children's & Women's Health Centre of BC, Vancouver

Sponsors
All Listed Sponsors
collaborator

Child and Family Research Institute

OTHER

lead

Children's & Women's Health Centre of British Columbia

OTHER